Overview

P. ZAFIROPOULOS S.A. is a Greek biotechnology company with over 30years of experience in developing and manufacturing innovative IVD products. P ZAFIROPOULOS S.A. is a pioneer in advanced clinical and laboratory diagnostic solutions through the integration of next generation flowcytometry platforms & advanced molecular analysis technologies. The Company partners with major, global diagnostic equipment manufacturers and provides a wide range of customized services to diagnostic and research laboratories across EU while its network expands across all sectors of Life Sciences. P. ZAFIROPOULOS S.A. is a key member of the Hellenic BioCluster (HBio), the first biosciences cluster in Greece. The Company specializes in: 1. Advanced diagnostic solutions, including state of the art diagnostic platforms as well data analysis and management solutions for the early detection and monitoring of severe diseases such as cancer and autoimmune diseases. 2. Cutting edge research and innovation by offering solutions in experimental design, including clinical validation assay development, novel biomarker detection and IVD reagents manufacturing. 3. Peak technology production line with permit from the National Pharmaceuticals Organization (EOF) and quality control procedures that ensure high reliability products and optimum performance. P. ZAFIROPOULOS S.A. has its headquarters and IVD manufacturing facilities in Koropi (Attika) with branch offices in Alimos - Athens and in Thesaloniki.